A 56-year-old man was referred with asymptomatic elevation of pancreatic hydrolase levels. Magnetic resonance imaging (MRI) delineated a pancreatic lesion with a low T1 and high T2 signal (• " Fig. 1 ). Endoscopic ultrasound (EUS) found an oval, well-defined, isoechogenic, homogeneous mass in the pancreatic parenchyma, without any vascular invasion and no locoregional lymph nodes (• " Fig. 2) . Fine-needle aspiration (FNA) showed small epithelioid cells. Immunostaining was positive for antichromogranin, antisynaptophysin, and anti-KI-67 (5 %), and a few cells were positive for anti-CD56. This was consistent with a neuroendocrine tumor (NET). Octreotide positron emission tomography combined with computed tomography (PET-CT) showed a focal uptake into the pancreas without any other nonphysiological uptake (• " Fig. 3 ). CA19 -9 and chromogranin levels were normal. Caudal pancreatectomy with spleen preservation was performed. Histological examination found no proof of NET but did reveal an intrapancreatic accessory spleen (IPAS) (• " Fig. 4 ). The postoperative period and follow-up were satisfactory. Accessory spleens may be found in 15 % of the population but are rarely located in the pancreatic tail (17 % A rare case of a pancreatic mass due to accessory spleen; when EUS-FNA is not enough Fig. 1 Endoscopic ultrasound shows an oval, well-defined, isoechogenic, homogeneous, 14-mm mass located in the pancreatic tail. There is no cystic component or calcification (SA, splenic artery; SV, splenic vein). 
